Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1991 Oct;32(4):516–518. doi: 10.1111/j.1365-2125.1991.tb03942.x

The pharmacokinetics of oxycodone after intravenous injection in adults.

R Pöyhiä 1, K T Olkkola 1, T Seppälä 1, E Kalso 1
PMCID: PMC1368617  PMID: 1958450

Abstract

Oxycodone chloride (0.07 mg kg-1) was given by intravenous bolus to nine young adult surgical patients on the first postoperative day. Plasma was sampled for up to 12 h. Mean values of t1/2z, CL and Vss were 222 min, 0.78 l min-1 and 2.60 l kg-1, respectively. The concentrations of the metabolite noroxycodone was also measured. The mean AUC(0,12) ratio of noroxycodone to oxycodone was 0.33. Oxymorphone was not detected.

Full text

PDF
517

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Hoskin P. J., Hanks G. W., Aherne G. W., Chapman D., Littleton P., Filshie J. The bioavailability and pharmacokinetics of morphine after intravenous, oral and buccal administration in healthy volunteers. Br J Clin Pharmacol. 1989 Apr;27(4):499–505. doi: 10.1111/j.1365-2125.1989.tb05399.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Kalso E., Vainio A., Mattila M. J., Rosenberg P. H., Seppälä T. Morphine and oxycodone in the management of cancer pain: plasma levels determined by chemical and radioreceptor assays. Pharmacol Toxicol. 1990 Oct;67(4):322–328. doi: 10.1111/j.1600-0773.1990.tb00838.x. [DOI] [PubMed] [Google Scholar]
  3. Osborne R., Joel S., Trew D., Slevin M. Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide. Clin Pharmacol Ther. 1990 Jan;47(1):12–19. doi: 10.1038/clpt.1990.2. [DOI] [PubMed] [Google Scholar]
  4. Saarialho-Kere U., Mattila M. J., Seppälä T. Psychomotor, respiratory and neuroendocrinological effects of a mu-opioid receptor agonist (oxycodone) in healthy volunteers. Pharmacol Toxicol. 1989 Oct;65(4):252–257. doi: 10.1111/j.1600-0773.1989.tb01168.x. [DOI] [PubMed] [Google Scholar]
  5. Wagner J. G. Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data. J Pharmacokinet Biopharm. 1976 Oct;4(5):443–467. doi: 10.1007/BF01062831. [DOI] [PubMed] [Google Scholar]
  6. Weinstein S. H., Gaylord J. C. Determination of oxycodone in plasma and identification of a major metabolite. J Pharm Sci. 1979 Apr;68(4):527–528. doi: 10.1002/jps.2600680441. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES